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INTRODUCTION
Lithium is widely used in the treatment of bipolar disorders, 
refractory depressive disorders, and in the long-term 
prophylaxis of cluster headache. It has a narrow therapeutic 
index. Chronic lithium intoxication is more common. There 
is gradual accumulation of lithium, usually due to decreased 
excretion. Lithium poisoning causes impaired renal function, 
drug interactions, volume depletion, and concurrent illnesses 
such as congestive heart failure or cirrhosis.[1,2] Lithium exerts 
its effects on a wide range of cellular functions by inhibiting 
inositol production, affects the protein kinase C signaling 
pathway, and inhibits glycogen synthase kinase 3 (GSK3).  [3] 
Early recognition and management of lithium-induced organ 
toxicity can save lives and reduce significant morbidity.
In the Ayurvedic system of medicine, Solanum trilobatum L. 
(Solanaceae) (common name: Tuduvalai) have been 
used for respiratory, cardiac, liver, renal, and cancer 
diseases.  [4] Sobatum, alpha-solamarine, solanine, solasodine, 
glycoalkaloid, diosogenin, and tomatidine are the 
constituents isolated from this plant.[5] Previous studies 
in our lab proved that treatment with S. trilobatum extract 
enhance the recovery from carbon tetrachloride-induced 
hepatic damage in rats.[6] It was also reported that 
S. trilobatum possesses anti-inflammatory, anti-ulcerogenic, 
and antimicrobial activities.[7,8] In our laboratory, sobatum 
has been isolated and purified to homogeneity from 
herb S. trilobatum and believed to be an active principle 
responsible for its beneficial action on vital organs. Earlier 
studies proved that sobatum has the antitumor property 
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and produce no toxicities.[9] Sobatum also possesses 
anti-inflammatory and free radical scavenging activities 
by inhibiting superoxide radical production.[10,11] These 
points made us interested to do research on sobatum 
against lithium-induced toxicity. However, no studies have 
been performed to study whether sobatum have beneficial 
effects on lithium carbonate (Li2CO3)-induced toxicity in 
experimental models of organ injury, which may have 
implications in managing humans with accidental exposures 
to such compounds.
Considering above information, the present study aims 
to investigate the effect of sobatum on toxicity caused by 
Li2CO3 in liver, heart, and kidney tissues of experimental 
rats through evaluating lipid peroxidative content, hepatic 
lipid levels, antioxidant enzymes, adenosine triphosphate 
(ATP) levels, apoptotic cell death, and histological changes.
MATERIALS AND METHODS
Chemicals
All chemicals and reagents were of analytical grade or of 
highest purity, commercially available. Lithium carbonate, 
glutathione, disodium phenyl phosphate, and bovine 
serum albumin were purchased from Sigma Chemical Co., 
St Louis, MO, USA. EDTA, DNAase, and proteinase K 
were purchased from British Drug House Pvt. Ltd Glaxo 
Division, Mumbai, India.
Plant materials and extraction of sobatum
The whole plant of Solanum trilobatum was collected in 
and around Chennai, India, and authenticated in the 
Department of Pharmacognosy, Captain Srinivasa Murthi 
Drug Research Institute for Ayurveda, Chennai, India. 
A voucher specimen has been deposited in the same 
institute (No: 1785). The plant samples were shade-dried 
and powdered using an electric blending machine. For 
the preparation of the extract, 100 g of powdered plant 
material was subjected to extraction with 90% petroleum 
ether in a Soxhlet apparatus up to four cycles. After 
filtration through Whatman filter paper no. 40, the filtrate 
was dried using a lyophilizer.
The petroleum ether extract of S. trilobatum was subjected to 
chromatography using Spherisorb-ODS2 25 cm 3 4.6 cm, 
5 cm, C18 silica column using water and petroleum ether/
ethyl acetate (75:25) as a solvent at a flow rate of 1 ml/min. 
These fractions were concentrated and crystallized from 
solvent giving only one pure crystalline compound that was 
identified and compared with authentic sample. For oral 
administration, the sobatum compound was dissolved in 
0.5 ml of 10% dimethyl sulphoxide (DMSO) immediately 
before use.
Animals
Adult male albino rats of Wistar strain weighing about 
150-200 g were purchased from Fredrick Institute, 
Padapai, India. The animals were housed at 27 6 2°C 
temperature, 55% humidity, and a 12 h-light/dark cycle. 
They were fed with standard laboratory chow (Hindustan 
Lever Foods, Bangalore, India) and provided with water 
ad libitum. Experimental protocols were approved by our 
Institute ethical committee, which follows the guidelines 
of Institutional Animals Ethics Committee (IAEC) 
(360/01/a/CPSEA).
Experimental design
Animals were divided into four groups each containing 
six animals. Group I animals served as control who received 
the vehicle (0.5 ml of 10% DMSO) alone orally. Group II 
animals constituted the toxicity group, who received Li2CO3 
(150 mg/kg body weight) orally in drinking water for a 
period of 30 days.[12] Group III animals received Li2CO3 
(150 mg/kg body weight) orally in drinking water for a 
period of 30 days and treated simultaneously with sobatum 
orally at doses (30 mg/kg body weight/day)[13] dissolved in 
0.5 ml of 10% DMSO. Group IV rats received sobatum 
orally at doses (30 mg/kg body weight/day) dissolved in 
0.5 ml of 10% DMSO.
After 24 h of sobatum last dose treatment, animals were 
sacrificed by cervical decapitation under pentobarbitone 
sodium (60 mg/kg) anesthesia and blood was collected 
without  an  anticoagulant  to  separate  serum  for 
biochemical investigation. The liver and heart organ were 
dissected out immediately and washed in ice-cold saline. 
The tissues were then homogenized in ice-cold Tris-HCl 
buffer (0.1 M, pH 7.4) and 10% homogenate was obtained 
and used for the following biochemical investigations.
Determination of lipid peroxidation and reduced 
glutathione levels
LPO was measured in hepatic homogenates according 
to the method of Okhawa et al. based on the formation 
of thiobarbituric acid reactive substances (TBARS) and 
expressed as the extent of malondialdehyde (MDA) 
production.[14] 
Glutathione (GSH) levels were quantified by the method of 
Moron et al.(1979).[15] The tissue homogenate was treated 70   J Young Pharm Vol 2 / No 1
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with 1 ml of 5% TCA in 1 mM EDTA and centrifuged at 
2000 g for 10 min. After that 1 ml of the filtrate was mixed 
with 5 ml of 0.1 M phosphate buffer (pH 8.0), and 0.4 ml 
of 5,5’-dithiobis (2-nitrobenzoic acid). The absorbance of 
the solutions was estimated at 412 nm against blank. The 
level of ATP in the heart tissue was determined by the 
method of Ryder.[16] 
Estimation of antioxidant enzymes
The activity of superoxide dismutase (SOD) was measured, 
using an assay based on the ability of SOD to inhibit the 
autoxidation of pyrogallol by 50%. One unit of enzyme is 
defined as the amount of enzyme that causes half maximal 
inhibition of pyrogallol autooxidation/mg protein/min.  [17] 
The assay of catalase was performed by following the 
method of Aebi. One unit of enzyme activity is defined as 
the amount of enzyme required to decomposed 1 mmol 
of H2O2/mg protein/min.[18] The activity of glutathione 
peroxidase (GPx) was measured using a coupled enzyme 
assay as described by Lawrence and Burk.[19]
Estimation of lipid profile
Lipid was extracted from liver tissues by the method 
of Folch et al. using the chloroform-methanol mixture 
(2:1 v/v).[20] The total cholesterol, free cholesterol, free 
fatty acids (FFA), triglyceride (TG), phospholipids (PL) 
after perchloric acid digestion have been determined in 
liver tissues of sobatum-treated rats.[21-25]
Histopathology
The heart tissue samples were preserved in 10% neutral 
buffered formalin for 24 h, processed for routine paraffin 
block preparation, sections of 5mm thick were cut and 
stained with hematoxylin and eosin. These were examined 
under the light microscope for histological changes in tissues.
Studies on DNA damage
The kidney tissue was used for the isolation of DNA 
by homogenizing in PBS-E (50 mM sodium phosphate 
buffer containing 0.9% saline and 20 mM EDTA, pH 8) 
and suspended in 2 ml of PBS-E containing 0.5 mg/  ml 
of collagenase. The suspension was incubated at 37°C 
for 1 h with stirring, followed by the addition of pronase 
E (1 mg ml), and further incubated for 15 min at 37°C. 
It was then centrifuged at 1000 rpm for 5 min. The pellet 
was dispersed and incubated with 2 ml of a lysis buffer 
containing 50 mM Tris-HCl2, pH 8, 20 mM EDTA, 10 mM 
NaCl and 1% w/v SDS for 15 min. It was centrifuged 
again at 14,000 3 g for 15 min, and DNA was isolated 
from the lysate by a phenol-chloroform extraction 
procedure.[26] DNA was dissolved in 10 mM Tris-HCl2, 
pH 8, containing 1 mM EDTA by gentle shaking at 65°C. 
Residual contaminating RNA was removed by incubating 
the DNA solution with 1 mg/ml DNase-free RNase at 37°C 
for 1 h followed by 0.1 mg ml proteinase K for 3 h. Phenol-
chloroform extraction was repeated to obtain purified 
DNA that was dissolved in 10 mM Tris-HCl2 buffer, pH 
8, containing 1 mM EDTA. To study DNA fragmentation, 
DNA was loaded on to a 1.5% agarose gel. In addition to 
compare the test samples with the standard antioxidant 
1 mg of catalase was used and electrophoresis was carried 
out at 100 V for 1.5 h in TBE (90 mM Tris borate, 2 mM 
EDTA, pH 8) buffer and DNA was visualized by UV 
exposure after staining with ethidium bromide.
Statistical analysis
Data are expressed as mean 6 SD. The results were 
computed statistically (SPSS software package, version 11.0) 
using one-way analysis of variance. Post hoc testing was 
performed for inter-group comparison using the Dunnett’s 
‘t ’ test. P , 0.001, P , 0.01, P , 0.05 were considered to 
be statistically significant.
RESULTS
Compared with controls, lithium-toxicated rats were 
accompanied by increased TBARS production and 
decreased antioxidant defense enzyme activities, suggesting 
oxidative stress in liver tissue [Table 1]. Administration of 
sobatum led to a marked reduction in the level of TBARS 
and significant enhancement in antioxidant defense enzyme 
activities as compared to lithium-treated rats. On the other 
hand, in sobatum-alone-treated rats, no significant change 
in enzyme activities could be observed, as compared to that 
of normal control.
Li2CO3 caused a significant increase in free cholesterol, 
total cholesterol, triglycerides, phospholipds, and fatty acid 
content as compared to the corresponding control group. 
Table 1: Effect of sobatum on the changes of liver 
antioxidant defense enzyme activities in Li2CO3 
administered rats
Groups SOD CAT GPx TBARS GSH
I 8.6160.45 4.8160.19 0.0260.001 0.5660.04 5.9860.03
II 6.5160.32* 2.9860.15* 0.0560.003* 1.0260.09* 3.9960.02*
III 8.1760.35a 4.0160.23a 0.0460.002a 0.7060.05a 4.8260.03a
IV 8.6460.41 4.8360.31 0.0260.001 0.5460.04 6.0160.05
Results are expressed as mean6SD for groups of six animals each; SOD: Superoxide 
dismutase; CAT: Catalase; GPx- Glutathione peroxidase: U/mg protein. TBARS-
nmoles/mg protein; GSH-reduced glutathione - mg of GSH/mg protein. Values are 
expressed as significant difference at *P ,0.001 as compared with control group; 
significant difference at aP ,0.001 as compared with Li2CO3 alone administered ratsJ Young Pharm Vol 2 / No 1  71
Chemoprotective effect of Sobatum
Sobatum treatment showed a marked protection against 
this enhanced lipid levels in the liver tissue of Group II 
rats [Figure 1]. No significant differences were observed 
between normal and sobatum-treated rats. Lipid levels 
and other biochemical parameters were not altered upon 
sobatum treatment.
Figure 2 shows the level of myocardial ATP content 
in normal and experimental groups of rats. Significant 
reduction in the level of ATP content in the heart tissue 
of lithium-induced rats as compared to that of Group I 
rats. The administration of sobatum maintained the level 
of ATP at near normalcy in Group III rats as compared to 
that of Group II rats, reflecting its ability to maintain the 
function of the heart mitochondria at near normal status.
Microscopic examination of heart tissue of the Group I 
control rats showed normal myocardial fibers and 
muscle bundles with normal architecture. Heart tissue 
of Group II rats showed separation of myocardial fibers 
with inflammatory mononuclear collections, edema, and 
myocardial necrosis. Sobatum-alone-treated Group IV rats 
showed normal myocardial fibers with no pathological 
changes. Myocardial section of sobatum-treated Group III 
rats showed slightly separated myocardial fibers with small 
focus of inflammatory mononuclear collections with the 
absence of necrotic damage [Figure 3].
Agarose gel electrophoresis of kidney tissue DNA, treated 
with or without sobatum in Li2CO3-treated rats is shown in 
Figure 4. Control rat and sobatum-treated rat showed the 
absence of DNA fragmentation in kidney tissue, which was 
observed in Lane 3 and Lane 4. In Lane 1, the toxic effects 
of Li2CO3 were reflected in a significantly higher rate of 
apoptosis in kidney tissue of Group II rats so no DNA 
band was observed. However, in Lane 2, Li2CO3-induced 
DNA fragmentation was markedly reduced by treatment 
with sobatum suggesting its role to prevent cell death. 
Sobatum provides significant protection against DNA 
damage in comparison with the already known antioxidant, 
catalase (Lane 5) suggesting its antiapoptotic role during 
oxidative damage. 
DISCUSSION
Lithium toxicity represents a state of increased oxidative 
stress, which is mainly based on the evidence of increased 
lipid peroxidation (LPO), or by indirect evidence of reduced 
antioxidant reserve, such as SOD and catalase enzymes, in 
animal models.[27] Sobatum have been reported to play a 
beneficial role in the reduction of free radical production.[11] 
In our present study, the administration of sobatum exerted 
beneficial effects against lithium toxicity followed by the 
fall in lipid peroxidation products. During physiological 
states, SOD metabolizes superoxide anion (O2
2), producing 
hydrogen peroxide (H2O2), which can react with iron to 
generate highly reactant hydroxyl radicals via the Fenton 
reaction. CAT is the most important peroxidase in 
detoxifying excess hydrogen peroxide to prevent hydroxyl 
production. Thus an increase in SOD or CAT levels per se 
does not necessarily indicate increased oxidative stress, 
whereas an imbalance between SOD and CAT activities 
could lead to an excessive generation of free radicals.[28] 
The antioxidative defense system like SOD, CAT, and GPx 
showed lower activities in liver during toxicity condition. 
Treatment of the lithium-induced animals with sobatum 
restored the altered activities of SOD, CAT, and GPx. This 
study suggests that possible mechanism of this protective 
Figure 1: Effect of sobatum on the levels of total cholesterol (TC), free 
cholesterol (FC), triglyceride (TG), phospholipid (PL) and free fatty 
acid (FFA) in the liver tissue of Li2CO3 administered rats. Results are 
expressed as mean ±SD for groups of six animals each. *P<0.001 
as compared to control;  aP<0.01 as compared to Li2CO3 alone 
administered rats
Figure 2: Effect of sobatum level of adenosine triphosphate in heart 
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Figure 4: Effect of sobatum on lithium carbonate-induced DNA 
fragmentation in rats
activity against lithium toxicity may be due to free radical-
scavenging and antioxidant activities.[5]
Lithium-induced elevation in lipid levels could be due 
to increase in biosynthesis and decrease in its utilization. 
Li2CO3 induces free radicals, which may cause cellular 
cholesterol accumulation, by increasing cholesterol 
biosynthesis and its esterification. The significant increase 
in the rate of TG, PL, and FFA synthesis by the liver is a 
well-known risk of toxicity caused by Li2CO3.[29] Abnormal 
activities of lipid-metabolizing enzymes contributed 
to these hyperlipid changes in liver caused by Li2CO3. 
S. trilobatum is a hypolipidemic agent, which reduces the 
rise in total cholesterol, free cholesterol, TG, FFA, and 
PL.[30] In addition, antioxidants such as sobatum could be 
beneficial in preventing the increase in lipidemic status, 
suggesting that it would prevent the toxicity of Li2CO3 on 
lipid metabolism.
In the heart, ATP is synthesized mainly in the mitochondria 
through oxidative phosphorylation and transported to 
Figure 3: Sections of heart tissue obtained from rats of control groups and treated with sobatum in lithium carbonate-induced rats. (H and E, 3100)J Young Pharm Vol 2 / No 1  73
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the contractile apparatus, where it is consumed by myosin 
ATPase to generate force. The viability of the cell depends 
for the most part on the integrity of several vital subcellular 
systems, and the major source of energy for contraction 
comes from the oxidative metabolism of mitochondria 
in the cell. In the present study, administration of 
sobatum maintained the level of ATP at near normalcy in 
Group III rats as compared to that of lithium-induced rats, 
reflecting its ability to maintain the function of the heart 
mitochondria at near normal status. Many recent evidences 
indicated that mainly heart damage may result from 
Li2CO3 intoxication[31] which was evident in the present 
study by histopathologic findings. Protection against heart 
damage in sobatum-treated rats showed normal functional 
cytoarchitecture of heart tissues.
Involvement of ROS, oxidative damage of DNA, and 
DNA fragmentation has also been evident in apoptotic cell 
death in renal injury.[32] Cytotoxic effects of Li2CO3 that 
affect the liver tissue are manifested by the disturbances of 
NO, a key mediator of signaling events linked to apoptotic 
cell death.[33] Sobatum prevents Li2CO3-induced DNA 
fragmentation, suggesting its antiapoptotic role to block 
cell death during damage. Sobatum could have a unique 
capacity to block this oxidative damage similar to that 
shown by H2O2 scavenger, catalase, indicating its potent 
antioxidant role to protect DNA from the attack of ROS. 
CONCLUSION
The results of the present study indicate that administration 
of sobatum attenuates lithium-induced organ toxicity 
in rats through counteraction of free radicals by its 
antioxidant property, antiapoptotic effect by blocking 
DNA fragmentation and attenuation of toxic changes in 
vital organs. 
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